The Medicine Became Permission
Published on: 01/07/2026
81% of Type 2 diabetes patients stay in poor glycemic control on medication. The drug isn't failing them — the feedback loop is. Dr. Terrence Vandiver explains the belief underneath why.

81% of Type 2 diabetes patients stay in poor glycemic control on medication. The drug isn't failing them — the feedback loop is. Dr. Terrence Vandiver explains the belief underneath why.

GLP-1 medications like Mounjaro and Ozempic are powerful tools — but they work on biology, not behavior. Here's why adding a structured protocol produces results the medication alone can't.